Cardiac failure
Not yet recruitingStudy on COR-1167 for Patients with Worsening Heart Failure
- Disease:Cardiac failure
- Substances:–
Poland- Participants:18–64 years · 65+ years
- Sponsor:Corteria Pharmaceuticals
Rare diseases
Investigational molecules
Locations
Back to Poland48 clinical trials in Walbrzych, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple myeloma and leukemia treatments, including novel combination therapies and targeted approaches for both newly diagnosed and relapsed/refractory cases.
Several trials are evaluating innovative drug combinations to improve patient outcomes and survival rates.
Comprehensive studies investigating treatments for various lymphoma types, with particular emphasis on follicular lymphoma and diffuse large B-cell lymphoma.
Research focuses on comparing new therapeutic options against current standard treatments.
Innovative trials examining treatments for myelodysplastic syndrome and myeloproliferative disorders, including studies of novel agents for anemia management.
These studies aim to improve quality of life and treatment outcomes for patients with various blood disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.